VR1 vanilloid receptor antagonists with a iononic substructure

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S307000

Reexamination Certificate

active

07919624

ABSTRACT:
The invention provides compounds of formula (I), wherein Y, R, n and X are as defined in the description, a process for their preparation and pharmaceutical compositions containing them. The compounds of formula (I) inhibit the Transient Receptor Potential Vanilloid 1 (TRPV1), which plays a pivotal role in the development of post-inflammatory analgesia, therefore they can be used as analgesic and anti-inflammatory drugs.

REFERENCES:
patent: 03/024920 (2003-03-01), None
patent: 03/049702 (2003-06-01), None
patent: 2004/056774 (2004-07-01), None
Doherty, Elizabeth M et al: “Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides,” Journal of Medicinal Chemistry, vol. 48, No. 1, pp. 71-90, Jan. 13, 2005.
Gunthorpe M J et al: “Identification and characterization of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist, ”Neuropharmacology, Pergamon Press, Oxford, GB, vol. 46, No. 1, pp. 133-149, Jan. 2004.
Shimasake H et al: “Retinoidal dienamides and related aromatic amides. Replacement of the 9-ene structure of retinoic acid with a trans- or cis-amide group,” Chemical and Pharmaceutical Bulletin 1995, Japan, vol. 43, No. 1, pp. 100-107, 1995.
PCT International Search Report for PCT/EP2007/005844 filed on Jul. 2, 2007 in the name of Pharmeste S.R.L.
PCT Written Opinion for PCT/EP2007/005844 filed on Jul. 2, 2007 in the name of Pharmeste S.R.L.
PCT International Preliminary Report on Patentability for PCT/EP2007/005844 filed on Jul. 2, 2007 in the name of Pharmeste S.R.L.
PCT International Search Report for PCT/EP2007/005835 filed on Jul. 2, 2007 in the name of Phameste S.R.L.
PCT Written Opinion for PCT/EP2007/005835 filed on Jul. 2, 2007 in the name of Phameste S.R.L.
Giovanni Appendino et al., “Clinically Useful Vanilloid Receptor RPVI Antagonists: Just around the Corner (or too Early to Tell)?”, Progress in Medicinal Chemistry 2006, 44, 145-180.
Timor Baasov et al., “C-C Stretching Frequencies in Model Compounds of the Protonated Retinal Schiff Base”, Angew. Chem. 1984, 23, 803-804.
P.G. Baraldi et al., “A Facile, Efficient of 2-substituted-4-Hydroxy-2-cyclopenten-1-ones”, S. Synthesis 1986, 9, pp. 781-782.
Yoshihisa Kudo et al., “Monitoring of Intracellular Ca2+ Elevation in a Single Neural Cell Using a Fluorescence Microscope/Video-Camera System”, Japan. J. Pharmacol. 41. 345-351 (1986).
Peter Meier et al, “Synthesis of Fonnylphenylpyridinecarboxylic Acids Using SuzukiMiyaura Coupling Reactions”, Synthesis 2003, 4, pp. 551-554.
Peter J. Munson et al., “Ligand: A Versatile Computerized Approach for Characterization of Ligand-Binding Systems”, Analytical Biochemistry 107, 220-239 (1980).
M. Nanasawa et al., “The Favorskii-type Rearrangement of 3-Bromo-b-ionone with Sodium Ethoxide”, Bull. Chem. Soc. Jpn. 1982, 55, 3655-3656.
Michela Rigoni et al., “Neurogenic responses mediated by vanilloid receptor-I (TRPVI) are blocked by the high affinity antagonist, iodo-resiniferatoxin”, British Journal of Pharmacology (2003) 138, 977-985.
Wen-Chung Shieh et al., “A Simple Asymmetric Synthesis of 4-Arylphenylalanines via Palladium-Catalyzed Cross-Coupling Reaction of Arylboronic Acids with Tyrosine Triflate”,J. Org. Chem.1992, 57, 379-381.
Arpad Szallasi et al., “[3H] resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents”, Naunyn-Schmiedeberg's Arch Pharmacol (1993) 347:84-91.
Arpad Szallasi et al., “Resiniferatoxin”, M. Neurosciences 1992, 8, 368.
Jidong Zhang et al., “A colored dendrimer as a new soluble support in organic synthesis. Part 1: Suzuki reaction”, Tetrahedron Letters 42 (2001) 6683-6686.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

VR1 vanilloid receptor antagonists with a iononic substructure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with VR1 vanilloid receptor antagonists with a iononic substructure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VR1 vanilloid receptor antagonists with a iononic substructure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2658868

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.